Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
The paper reviews the results of the GALAXY international programme, a series of clinical (mostly comparative) studies of various statins. It has demonstrated the benefits of rosuvastatin in terms of normalization of lipid profile, inflammatory markers, and coronary or cerebrovascular atherosclerosi...
Saved in:
| Main Authors: | A. N. Britov, M. P. Chupina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1495 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid-lowering and pleiotropic effects of rosuvastatin in patients with acute myocardial infarction
by: N. A. Dzhaiani, et al.
Published: (2008-12-01) -
LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01) -
Lipid lowering and additional pleiotropic effects of statins
by: Ali Çoner, et al.
Published: (2025-04-01) -
Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01) -
Modern views on clinical and economical effectiveness of rosuvastatin
by: S. K. Zyryanov, et al.
Published: (2008-02-01)